Table 1.
Kidney | Kidney pancreas | |
---|---|---|
Number recruited | 42 | 19 |
Sex male/female | 31M/11F | 9M/10F |
Median age (range) | 54 (26–74) | 47 (30–59) |
Donor type | ||
Living (male/female) | 16 (11M/5F) | n/a |
DBD (male/female) | 11 (7M/4F) | 16 (7M/9F) |
DCD (male/female) | 15 (13M/ F) | 3 (2M/1F) |
Drug treatment regimen | ||
Alemtuzumab | 19 | 19 |
Basiliximab + MMF | 13 | n/a |
Basiliximab + Aza | 10 | n/a |
61 patients were recruited in total.
DBD, donor after brainstem death; DCD, donor after cardiac death; MMF, mycophenolate mofetil; Aza, azathioprine.